share_log

Invitation to the presentation of Elekta's second quarter 2021/22

Invitation to the presentation of Elekta's second quarter 2021/22

邀請介紹Elekta的2021/22第二季度
PR Newswire ·  2021/11/04 03:26

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day.

斯德哥爾摩,2021年11月4日/美通社/--Elekta(Ekta-B.ST)邀請分析師和投資者參加2021/22年第二季度的演示,時間為上午10:00。CET ON11月25日。第二季度中期報告將於上午7:30發佈。美國東部時間同一天。

The company's development will be presented by Elekta's President and CEO, Gustaf Salford, together with CFO, Johan Adebäck. After the presentation, held in English, a Q&A session will follow.

Elekta總裁兼首席執行官古斯塔夫·索爾福德(Gustaf Salford)將與首席財務官一起介紹公司的發展情況。約翰·阿德巴克(Johan Adebäck)。演講結束後,將舉行英語演講,隨後是問答環節。

The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta's website after the call.

演講將在網上直播。如果你打算提問,有必要參加電話會議。電話會議結束後,可以在Elekta的網站上找到網絡直播的錄音。

Welcome!

歡迎!

Time: Thursday, November 25, at 10:00 a.m. CET

時間:11月25日(星期四)上午10點塞特

Telephone numbers to join phone conference:
UK: +44 333 300 9035 
USA: +1 646 722 4902
Sweden: +46 8 566 427 06 

加入電話會議的電話號碼:
英國:+44 333 300 9035
美國:+1 646 722 4902
瑞典: +46 8 566 427 06

Webcast: https://elekta-qreports.creo.se/211125

網絡直播:Https://elekta-qreports.creo.se/211125

# # #

# # #

For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: [email protected]
Time zone: CET (Central European Time)

如需更多信息,請聯繫:
塞西莉亞·凱特爾斯(Cecilia Ketels),投資者關係主管
電話:+4676611 7625,電郵:[受電子郵件保護]
時區:CET(中歐時間)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

關於埃列克塔
作為精確放射治療領域的領先者,Elekta致力於確保每一位患者都能儘可能獲得最好的癌症治療。我們開誠佈公地與客户合作,推動可持續、以結果為導向、以成本效益為導向的解決方案,以滿足不斷變化的患者需求,改善生活,併為每個與癌症抗爭的人帶來希望。對我們來説,這是個人的,我們由4700名員工組成的全球團隊將激情、科學和想象力結合在一起,深刻改變了癌症治療。我們不僅創造了技術,我們還創造了希望。艾樂達總部設在瑞典斯德哥爾摩,在120多個國家設有辦事處,並在納斯達克斯德哥爾摩上市。有關更多信息,請訪問elekta.com或在Twitter上關注@Elekta。

CONTACT:

聯繫方式:

This information was brought to you by Cision http://news.cision.com

此信息是由Cision http://news.cision.com為您帶來的

https://news.cision.com/elekta/r/invitation-to-the-presentation-of-elekta-s-second-quarter-2021-22,c3446424

Https://news.cision.com/elekta/r/invitation-to-the-presentation-of-elekta-s-second-quarter-2021-22,C3446424

The following files are available for download:

以下文件可供下載:

https://mb.cision.com/Main/35/3446424/1490902.pdf

Invitation to the presentation of Elekta's Q2_2021-22

Https://mb.cision.com/Main/35/3446424/1490902.pdf

邀請介紹Elekta的Q2_2021-22

SOURCE Elekta

來源Elekta

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論